Our core capabilities

Comprehensive CDMO pharma manufacturing services spanning clinical development, scale up, and commercial supply — enabling seamless progression from clinical trials to GMP manufacturing.

Small Molecules

Small Molecules

  • Custom synthesis & route scouting
  • Process development & optimization
  • Scale‑up from grams to commercial volumes
  • GMP manufacturing for clinical and commercial APIs
Supporting companies looking to outsource drug manufacturing with reliable scale up and regulatory compliance.
Read more
Peptides

Peptides

  • SPPS, LPPS & hybrid synthesis approaches
  • Large‑scale fragment manufacturing
  • Complex, long‑chain & high‑potency peptides
  • Clinical trials manufacturing and GMP peptide production for regulated markets
Delivering flexible solutions from early phase programs to commercial supply.
Read more

We solve complex chemistry challenges — and execute them at scale.

What Sets Neuland Apart

A trusted partner for innovators seeking CDMO pharma manufacturing, clinical development support, and scalable commercial supply

Complex Chemistry DNA

Not just scale — we are recognized for chemical problem solving, process maturity, and robustness.

CDMO Execution

Seamless support from early development and clinical trials to commercial GMP manufacturing

Hybrid Capability Advantage

Seamlessly combining solid phase and liquid phase synthesis to optimize yield, timelines, and cost.

Regulatory Confidence

Strong inspection history and documentation rigor for US FDA and global markets.

Have a Molecule You’re Evaluating for Scale‑Up or GMP Manufacturing?
 

Discuss your early development, clinical trials manufacturing, GMP manufacturing requirements, or outsourcing needs with our scientific experts.

Whether you're advancing a clinical candidate or scaling a commercial product, we provide the expertise and infrastructure to accelerate your program.

Case Studies: Solving complex development & scale‑Up challenges

Phase II Peptide API

Phase II Peptide API

De‑Risking a Complex Program at Clinical Scale
Read case study
Preclinical Small Molecule API

Preclinical Small Molecule API

Rescuing a Low‑Yield Route for Rapid Progression
Read case study
Phase III to Commercial CNS API

Phase III to Commercial CNS API

Converting a High‑Risk CNS API into a Scalable Asset
Read case study